Oral Product Line

ChemWerth's goal is to offer the best source – not the first source. Using ChemWerth's APIs, you will receive the fastest FDA approval possible which is critical to your success in the highly competitive generic oral market. Our Regulatory expertise allows for customers to receive FDA approval in 12 to 15 months.

Acamprosate Calcium
Adapalene
Alosetron HCl
Aprepitant
Atorvastatin Ca Amorphous
Busulfan
Cevimeline
Ciprofloxacin HCl
Clindamycin HCl USP/PhEur
Clindamycin PO4 USP
Dasatinib
Dantrolene Na
Doxercalciferol**
Drospirenone
Entecavir
Exemestane
Ethosuximide USP

Granisetron HCl
Hydroxychloroquine SO4 USP**
Isradipine USP
Lubiprostone
Paricalcitol
Pentosan Polysulfate Sodium
Sirolimus**
Tacrolimus
Tacrolimus Premix
Temozolomide
Tiagabine HCl
Tizanidine HCl USP
Topiramate USP
Valacyclovir HCl
Valganciclovir HCl
Vancomycin HCl

** Pending Approval
Items denoted by blue text have been approved in the USA/EP